Enterprise Evidence Report · NR-REPORT-V2.0

France
Neuroscience Intelligence

France neuroscience evidence report: current clinical, research, institution and source-linked intelligence.

Evidence rank #2 of 50 · Data maturity A · Research score 52.5 · Data confidence 100.0 / 100 · Snapshot 2026-10-12 03:36 UTC.

⚗
556Curated trials
↗
148Recruiting trials
▦
407Publications
⌂
590Institutions

Executive interpretation

France ranks #2 in the current NeuroRisk evidence-ranked market layer. This ranking summarizes indexed clinical, publication and institution evidence; it is not a probability of commercial success and not an investment recommendation.

Methodology status

Methodology NR-REPORT-V2.0. No synthetic ML confidence is presented as scientific probability. Counts and source links below are tied to the generation snapshot.

Methodology →

Leading sponsors

Assistance Publique - Hôpitaux de Paris4012 recruiting
Hospices Civils de Lyon2613 recruiting
University Hospital, Montpellier214 recruiting
University Hospital, Toulouse204 recruiting
Hoffmann-La Roche186 recruiting
Merck Sharp & Dohme LLC186 recruiting
Assistance Publique Hopitaux De Marseille143 recruiting
University Hospital, Strasbourg, France134 recruiting
University Hospital, Bordeaux115 recruiting
Centre Hospitalier Universitaire de Nice114 recruiting

Disease activity

Alzheimers89trials
Parkinsons76trials
Epilepsy74trials
Autism40trials
Depression29trials
Other Neurology26trials
Adhd21trials
Other Psychiatry15trials
Neuromuscular14trials
Anxiety13trials

Research institutions

École Normale Supérieure de LyonOpenAlexlinked institution
Laboratoire de Génétique CellulaireOpenAlexlinked institution
Laboratoire Jean KuntzmannOpenAlexlinked institution
Laboratoire d’Imagerie BiomédicaleOpenAlexlinked institution
Centre de Recherche Saint-AntoineOpenAlexlinked institution
European Space AgencyOpenAlexlinked institution
Institut polytechnique de GrenobleOpenAlexlinked institution
Biologie cellulaire et CancerOpenAlexlinked institution

Clinical evidence trail

NCT07819851A Study of the Correlation Between the Severity of Substance Use Disorder and the Intensity of Dependence on Generative Artificial IntelligenceNOT_YET_RECRUITING
NCT07798674TreatHSP Platform: Adaptive Natural History Platform for Ataxias, HSPs, and Spastic AtaxiasRECRUITING
NCT07784595Comparison of an Initial Active Follow-up and Therapeutic Care on Functional Outcome and Quality of Life in Patients With Head and Neck ParagangliomasNOT_YET_RECRUITING
NCT07746050Value of Biomarkers of Brain Injury for Predicting Psycho-cognitive Sequelae Secondary to Sepsis: a Prospective Multicenter StudyNOT_YET_RECRUITING
NCT07740057Multimodal Study About Absence of Dp140 in Becker Muscular Dystrophy: Brain-muscle Imaging, Cognition and Muscle FunctionNOT_YET_RECRUITING
NCT07716982Estimation of Control Before and After Treatment of a Depressive Episode With Serotonin Reuptake InhibitorsNOT_YET_RECRUITING
NCT07686653A Study of the Value of Trio Genome Sequencing in the Etiological Evaluation of Early-Onset and/or Atypical Psychiatric Disorders Without Intellectual Disability or Congenital AnomaliesNOT_YET_RECRUITING
NCT07579611Efficacy of Spinal Cord Stimulation in Chemotherapy-Induced Peripheral NeuropathyNOT_YET_RECRUITING
NCT07545798Bright Light Therapy During Inpatient Cocaine DetoxificationRECRUITING
NCT07544563Phenotypic Exploration During Sensory Stimulation in an Acoustic ChamberRECRUITING
NCT07507240The Benefits of a Care Pathway Combining Remote Monitoring and Support From a Nurse After a Change in Anti-epileptic Treatment: a Pilot StudyNOT_YET_RECRUITING
NCT07499193Study of Blinking as a Function of Tear Film QualityNOT_YET_RECRUITING

Research evidence trail

PUBMEDNetwork analysis of the link between depressive symptoms and risk of suicidal behavior at three years: A national prospective study.2026-12-15
PUBMEDRetinal electrophysiology in mood disorders: Toward clinically relevant biomarkers. A systematic review and meta-analysis.2026-12-15
PUBMEDImpact of prone positioning on sleep and respiratory outcomes by polysomnography in Robin Infants: a cross-sectional study.2026-12-01
PUBMEDProlonged exposure in routine outpatient care: a naturalistic study of feasibility, safety and effectiveness.2026-12-01
PUBMEDTherapeutic intensification in post-traumatic stress disorder worldwide: where do we stand?2026-12-01
PUBMEDPrecarity and academic performances in undergraduate students: the serial mediating roles of insomnia symptoms and psychotic-like experiences.2026-12-01
PUBMEDTherapeutic strategies after discontinuation of valproate in females of child-bearing potential with bipolar disorder: an insurance claims database study in France and the United Kingdom.2026-12-01
PUBMEDDynamical system modeling in schizophrenia: a narrative review of computational psychiatry frameworks.2026-12-01
PUBMEDConnectome-based graph metrics predict electroconvulsive therapy response in adults with depression.2026-12-01
PUBMEDThe experience of professionals receiving patients with manifestations of traumatic dissociation: a qualitative study.2026-12-01
PUBMEDTrauma re-experiencing episodes during esketamine treatment in patients with treatment-resistant depression and comorbid PTSD: a retrospective case series.2026-12-01
PUBMEDMeal Timing Jetlag is associated with anxiety, depressive and insomnia symptoms in a French-speaking online cohort: A cross-sectional analysis of ALIMENTAL 2.2026-11-15

World Bank context

IT.NET.USER.ZSinternet_users_pct88.7% · 2024
NY.GDP.MKTP.CDgdp_current_usd$3,160.4B · 2024
NY.GDP.PCAP.CDgdp_per_capita_usd$46,103 · 2024
SE.PRM.ENRRschool_enrollment_primary_pct103.44 · 2024
SE.SEC.ENRRschool_enrollment_secondary_pct103.79 · 2024
SH.XPD.CHEX.GD.ZScurrent_health_expenditure_pct_gdp11.5% · 2024
SH.XPD.CHEX.PC.CDcurrent_health_expenditure_per_capita_usd$5,327 · 2024
SH.XPD.GHED.GD.ZSgovernment_health_expenditure_pct_gdp7.9% · 2024
SP.DYN.CBRT.INbirth_rate_crude9.70 · 2024
SP.POP.TOTLpopulation_total68,551,653 · 2024
SP.URB.TOTL.IN.ZSurban_population_pct78.8% · 2024

Macro indicators are shown only where a timestamped World Bank source row exists. They are context, not NeuroRisk predictions.

Sources and provenance

ClinicalTrials.gov provides NCT evidence. PubMed/NCBI and OpenAlex provide research metadata. OpenAlex links institutions. World Bank indicators are included only when an explicit source row and year exist. NeuroRisk transformations add normalization, ranking and graph connections.

Limitations

Indexed corpus counts are not guaranteed exhaustive global totals. Scores are comparative decision-support signals. This report is not medical advice, regulatory advice, patent clearance, an investment recommendation or a guarantee of outcome.